Notice of Effectiveness

Bicara Therapeutics Inc. Filed 2025-11-26 Acc 9999999995-25-003395

Documents 1

2025-11-26 EFFECT Notice of Effectiveness
2025-11-26 424B5 Prospectus
2025-11-25 4 Chief Executive Officer sold 41,163 shares at $18.86 ($776,429)
2025-11-25 4 Chief Financial Officer sold 18,400 shares at an average $18.54 ($341,074)
2025-11-25 4 President and COO sold 12,500 shares at $18.05 ($225,588)
2025-11-25 144 Sale of Securities
2024-09-12 EFFECT Notice of Effectiveness

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…